Synspira Therapeutics, CFF Agree to Support Development of SNSP003
The Cystic Fibrosis Foundation reached an agreement with Synspira Therapeutics to support further development of SNSP003 to treat malabsorption syndromes. Read more about it here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.